$TENX News Article - Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) https://marketwirenews.com/news-releases/tena...26102.html
(0)
(0)
Tenax Therapeutics Inc. (TENX) Stock Research Links